CRS in a Nutshell

A world’s leading full service early phase CRO

With four research units in the largest metropolitan regions of Germany and a total capacity of 200 in-house beds, CRS offers its clients innovative concepts and intelligent solutions in the field of early clinical development – from First-in-Human, Proof-of-Concept in patients.

With our outstanding expertise and vast experience, CRS is the ideal candidate for biopharmaceutical companies – regardless of their size – to establish a strategic or tactical project-related outsourcing partnership.

CRS – Partner with a remarkable track record

Besides the standard early phase clinical trials in healthy volunteers, CRS is also your partner to execute trials in patients – both, in monocentric or multicentric settings. Especially in the fields of metabolic and cardiovascular disorders and woman’s health we consistently demonstrate an extraordinary expertise. Also particularly noteworthy is our outstanding performance in conducting clinical trials in renal and hepatic impaired patients.

Overall, in the above listed fields but in other therapeutic areas too, CRS can show a remarkable track record.

Taking a drug to market is a long and exciting way on which one is often confronted with unexpected obstacles and challenges. Engaging early with experts is therefore of inestimable value.

We at CRS – with a wealth of experience gathered over more than 40 years – provide all our knowledge to best design your early phase drug development strategy.

Let’s Start with the Conversation